Human essential hypertension: no significant association of polygenic risk scores with antihypertensive drug responses.

Scientific Reports
Heini Sánez TähtisaloTimo P Hiltunen

Abstract

Polygenic risk scores (PRSs) for essential hypertension, calculated from > 900 genomic loci, were recently found to explain a significant fraction of hypertension heritability and complications. To investigate whether variation of hypertension PRS also captures variation of antihypertensive drug responsiveness, we calculated two different PRSs for both systolic and diastolic blood pressure: one based on the top 793 independent hypertension-associated single nucleotide polymorphisms and another based on over 1 million genome-wide variants. Using our pharmacogenomic GENRES study comprising four different antihypertensive monotherapies (n ~ 200 for all drugs), we identified a weak, but (after Bonferroni correction) statistically nonsignificant association of higher genome-wide PRSs with weaker response to a diuretic. In addition, we noticed a correlation between high genome-wide PRS and electrocardiographic left ventricular hypertrophy. Finally, using data of the Finnish arm of the LIFE study (n = 346), we found that PRSs for systolic blood pressure were slightly higher in patients with drug-resistant hypertension than in those with drug-controlled hypertension (p = 0.03, not significant after Bonferroni correction). In conclusion...Continue Reading

References

Sep 3, 2010·Nature·UNKNOWN International HapMap 3 ConsortiumJean E McEwen
Sep 13, 2011·Nature·UNKNOWN International Consortium for Blood Pressure Genome-Wide Association StudiesToby Johnson
Nov 7, 2012·Nature·UNKNOWN 1000 Genomes Project ConsortiumGil A McVean
Jan 11, 2013·European Heart Journal·Georg B Ehret, Mark J Caulfield
May 11, 2013·Circulation Research·Patricia B MunroeMark J Caulfield
Jan 30, 2015·Journal of the American Heart Association·John F Keaney, Joseph Loscalzo
Feb 20, 2015·Journal of Hypertension·Martina ChittaniCristina Barlassina
Mar 15, 2015·Circulation Research·Sandosh PadmanabhanAnna F Dominiczak
Oct 2, 2015·Journal of Hypertension·Yan GongJulie A Johnson
Oct 3, 2015·American Journal of Human Genetics·Bjarni J VilhjálmssonNick Patterson
Jan 31, 2017·Nature Genetics·Helen R WarrenUNKNOWN UK Biobank CardioMetabolic Consortium BP working group
Sep 18, 2018·American Journal of Human Genetics·Mary E HaasSekar Kathiresan
Sep 19, 2018·Nature Genetics·Evangelos EvangelouUNKNOWN Million Veteran Program
Apr 18, 2019·Nature Communications·Tian GeJordan W Smoller
May 16, 2019·Stroke; a Journal of Cerebral Circulation·Laura IbanezCarlos Cruchaga
Jul 30, 2019·Hypertension·Victor J Dzau, Celynne A Balatbat
Jan 25, 2020·Heart, Lung & Circulation·Patrick A GladdingRobert Doughty

❮ Previous
Next ❯

Citations

Jun 25, 2021·Journal of Internal Medicine·Kaya J OlczakPatricia B Munroe

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Software Mentioned

GENRES
SPSS General Linear Model
LIFE
QT Guard
SPSS

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Current Opinion in Lipidology
Mette Christoffersen, Anne Tybjærg-Hansen
Current Opinion in Lipidology
Mette Christoffersen, Anne Tybjærg-Hansen
BioRxiv : the Preprint Server for Biology
Brandon J Coombes, Joanna M Biernacka
© 2021 Meta ULC. All rights reserved